NCT03273270

Brief Summary

Freezing of gait (FoG) is a common and debilitating condition in Parkinson's Disease (PD) patients. FoG is described as an episodic inability to walk, which often triggers falls, hospitalization and is an important predictor of poor quality of life. As locomotor regions degenerate in PD, gait automaticity is impaired. Patients compensate by increasing volitional control of gait, however, this adaptation has been found to worsen FoG severity. We hypothesize that increased cortical control of gait is maladaptive, and therapies to improve gait automaticity will not be effective unless cortical control of gait is reduced. The long-term goal of this project is to develop a therapeutic approach for FoG that simultaneously reduces cortical control and increases automaticity of gait. The objective is to determine the locomotor network abnormalities responsible for FoG and demonstrate how neuromodulation and rehabilitation can modulate the network. The rationale of this study is that increased connectivity between brainstem locomotor regions and cortical structures represents increased cortical governance of gait, and it can be reversed by the proposed intervention. We will accomplish this by combining a course of inhibitory rTMS (1Hz) to the cortex (supplementary motor area) with a rehabilitation protocol designed to increase gait automaticity (dual task training). We have designed a study that will carefully assess the locomotor network of freezers with resting state functional, diffusion and interleaved TMS/BOLD MRI studies, before and after intervention. Behavioral measures including gait analysis, cognitive and motor assessments will also be conducted at baseline and post treatment. The study aims to determine the effects of our intervention on the locomotor network (assessed with imaging), as well as on FoG severity as quantified through multiple markers obtained through gait analysis. At the conclusion of the study we expect to have determined the network changes central to the pathophysiology of FoG, the effects of 1Hz rTMS + rehabilitation on this network, and on FoG severity. The relevance of this study to public health is to develop a non-invasive effective therapeutic option for one of the most debilitating and untreatable conditions affecting the lives of one million Americans suffering from PD; freezing of gait.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 31, 2017

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

August 28, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 6, 2017

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 23, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 23, 2020

Completed
1 year until next milestone

Results Posted

Study results publicly available

March 29, 2021

Completed
Last Updated

March 29, 2021

Status Verified

March 1, 2021

Enrollment Period

2.6 years

First QC Date

August 28, 2017

Results QC Date

February 10, 2021

Last Update Submit

March 3, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Functional Connectivity to the Supplementary Motor Area.

    Change (pre vs post intervention) in resting-state fMRI connectivity (fisher z-score) of the supplemental motor area (SMA). A negative change score means there was a reduction in SMA connectivity pre to post intervention. A positive change score means there was an increase in SMA connectivity pre to post intervention.

    pre and post intervention (within one week of completion)

Secondary Outcomes (2)

  • Change in New Freezing of Gait Questionnaire

    pre and post intervention (within one week of completion)

  • Change in Dual Task Time to Turn Off

    pre and post intervention (within one week of completion)

Study Arms (2)

Active TMS

EXPERIMENTAL

1 Hz repetitive transcranial magnetic stimulation

Radiation: transcranial magnetic stimulation

Sham TMS

PLACEBO COMPARATOR

No active stimulation

Radiation: transcranial magnetic stimulation

Interventions

transcranial magnetic stimulation

Active TMSSham TMS

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects meeting diagnostic criteria for PD and documented FoG

You may not qualify if:

  • Subjects with contraindications to MRI, or TMS (no history of seizures, no metal implants in head, no pregnancy) dementia, or inability to complete the walk 30 feet in the off state without assistance will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Location

MeSH Terms

Interventions

Transcranial Magnetic Stimulation

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Limitations and Caveats

Multiple variables were collected with gait analysis (i.e. velocity, step length, time) however, we hypothesized dual task time to turn during the OFF conditions would be most likely to change pre to post intervention. In order to minimize multiple comparisons among gait measures dual task time to turn was selected as the most important variable to detect freezing since turning and dual tasking are common triggers.

Results Point of Contact

Title
Gonzalo Revuelta
Organization
Medical University of South Carolina

Study Officials

  • Gonzalo Revuelta, DO

    Medical University of South Carolina

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 28, 2017

First Posted

September 6, 2017

Study Start

July 31, 2017

Primary Completion

March 23, 2020

Study Completion

March 23, 2020

Last Updated

March 29, 2021

Results First Posted

March 29, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations